Four cases of malignant lymphomas in elderly patients are reported, along with the results of immunohistochemistry and electron microscopy.
Some reports have indicated that Japanese oral NHL are mostly located in the gingiva , and that men are affected in about 60 % of cases. The majority of patients are in the 40 to 60-year range , while patients aged 80 years or over are few in number [1, 2] . In Japan since 1975 , 55 cases[3] of oral NHL in elderly patients, including the present cases, have been reported. Seventeen (30 .9 %) of the tumors were located in the gingiva, followed in order by the submandible (8 cases, 14.5 %) and other areas (30 cases, 54.6 %). Nodal lymphomas are surprisingly uncommon. The gingiva is the area most commonly affected by NHL in the oromaxillofacial region (Table 3 ). Men are affected 2 .2 times more often than women. Five of the previous patients were aged 85 years or more including the present case, and all were men (Table 4 ). The oldest patient was 88 years old, followed by an 87-year-old man, two were 86 years old (one of the present series), and the last patient was 85 years old. Among the women affected , the oldest was 83 years old. Generally, the average life span of Japanese men is shorter than that of women , but oral NHL affected men more often. Thus it is suggested that its histogenesis may be related to the participation of sex hormones as age advances.
For the histopathological classification of NHL, the Working Formulation[8] is generally used , but in Japan, the LSG classification [6] proposed by the Lymphoma-Leukemia Study Group is widely employed . Among the 55 cases mentioned above, 50 were distinguishable from their histopathological characteristics: 47 (94 %) were diffuse lymphomas and 3 (6 %) were follicular lymphomas (Table 5) . Of the cases occurring in non-elderly patients, 50 (83 %) were diffuse and 10 (17 %) were follicular . Thus it is clear that diffuse lymphomas are more predominant in elderly patients .
Formerly, B-and T-cell type lymphomas were distinguished by the morphological features of the tumor cell nuclei (cleaved: B cell, convoluted: T cell) .[9' Now the distinction can be made easily by immunohistochemical studies using monoclonal antibodies on paraffin sections.
[10] L26 as a Pan B marker , UCHLl as a Pan T marker and immunoglobulins (IgA, IgG, IgM, kappa chain and lambda chain) were used in the present study. When most of the tumor cells in Cases 1, 2 and 3 exhibited immunoreactivity for L26 and IgM, these cases were considered to be B-cell type lymphoma . However, some cells of Cases 1 and 2 were positive for UCHL1. Burns et al. [11] reported that B-cell NHL expressed Pan T marker, but Harris et al.
[12] and Mikata et al." considered that B-cell NHL contained non-neoplastic T cells . UCHL1-positive cells in Cases 1 and 2 had small nuclei and were scattered throughout the tumors . In view of the presence of precritical non-neoplastic T cells in chronic periodontitis (Case 1) and in submandibular lymph nodes (Case 2) , we considered that these Pan T-positive cells were not neoplastic . Generally, the prognosis of T-cell NHL is worse than that of B-cell NHL, and it is therefore important to determine which of these types is present . None of the tumor cells in Case 4 were reactive for both L26 and UCHL1 , but the cells were positive for IgG, indicating B-cell type lymphoma. Malignant B cell populations , being monoclonal, would be generally expected to manifest either kappa or lambda light chains . Picker et al. [14] reported that 9-55 % of NHL cases were light chain-negative. However, there was no immunoreactivity for light chain in the present cases. The reason for this is not clear, but may have been due to (1) heterogeneity , (2) reduction of staining intensity resulting from tumor degradation, or (3) technical error . Immunohistochemically, the combined use of antibodies against Pan B, PanT markers and immunoglobulins is useful for determining the tumor cell origin.
There have been relatively few studies of oral ML using immunohistochemistry and electron microscopy[3,4, [15] [16] [17] . In the present study, some tumor cells showed positivity for vimentin (Cases 1 , 2 and 4), KP1 and PG-M1 (Cases 1 and 2). As none of the cases were immunoreactive for other histiocytic , mesenchymal and epithelial markers, it seems that they were not histiocytic lymphomas or undifferentiated carcinomas. It has been reported that vimentin is expressed in B-cell lymphoma (58 .5 %) and T-cell lymphoma (24.2 %), and that vimentin expression in diffuse B-cell lymphomas, especially the small and medium cell types, is more frequent than in follicular lymphomas. [5] In the present study, vimentin was demonstrated in all diffuse B-cell lymphomas (medium cell type) and not in follicular lymphoma, confirming that vimentin is a useful marker for diagnosis of ML. Warnke et al. [18] reported that B-cell lymphomas (34 %) were reactive for KP1, whereas T-cell lymphomas were not. However, Falini et al. [19] found that NHL were PG-MInegative. In the present study, half of the cases (Cases 1 and 2) were stained for KP1 and PG-M1, indicating that KP1 and PG-M1 are valuable for diagnosis of B-cell lymphoma.
Electron microscopy demonstrated that the tumor cells in all cases contained large nuclei with clear nucleoli and scant cytoplasm which was rich in ribosomes and polysomes, indicating the cells had high metabolic and mitotic activity. Many tumor cells in Case 3 contained cleaved nuclei, a feature which has been reported to be characteristic of follicular lymphoma.
[4] The tumor cells in Case 3 contained many microfibrils and ribosomes, thus explaining the dark appearance of the cytoplasm upon electron microscopy. Most intercellular junctions of the tumor cells were smooth, but in Case 1 desmosomes were evident in some areas. Ghadially [20] considered that since lymphomas are non-epithelial tumors, they contain neither desmosomes nor desmosome-like structures, and that absence of cell junctions is characteristic of these neoplasms. However, Wakasa et al. [21] , Watanabe [22] and Shamoto [23] demonstrated desmosomes at tumor cell junctions in ML. Thus the present study supports the latter opinion. Table 2 Results of immunohistochemistry for tumor cells Table 5 Histopathological classification (Case)
